INFLAMMATORY BREAST CANCER
Clinical trials for INFLAMMATORY BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new INFLAMMATORY BREAST CANCER trials appear
Sign up with your email to follow new studies for INFLAMMATORY BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for aggressive breast cancer: adding immunotherapy to standard treatment
Disease control OngoingThis study is testing whether adding the immunotherapy drug pembrolizumab to standard chemotherapy before surgery helps eliminate aggressive inflammatory breast cancer tumors. It involves 52 adults with a specific type of breast cancer (HER2-negative) that has not spread. The mai…
Matched conditions: INFLAMMATORY BREAST CANCER
Phase: PHASE2 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug combo tested for aggressive breast cancer before surgery
Disease control OngoingThis study is testing whether adding the drug eribulin to standard chemotherapy works better when given before surgery for a specific aggressive type of breast cancer (HER2-negative inflammatory breast cancer). Researchers want to see if this drug sequence helps eliminate more ca…
Matched conditions: INFLAMMATORY BREAST CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for Tough-to-Treat breast cancer: experimental combo enters human trials
Disease control OngoingThis study is testing whether adding a new, experimental drug called onvansertib to a standard chemotherapy (paclitaxel) is safe and effective for people with triple-negative breast cancer that has spread. The first part finds the safest dose, and the second part checks if the co…
Matched conditions: INFLAMMATORY BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Antonio Giordano, MD • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC